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Abstract
Organophosphate compounds (OPs) induce both acute and delayed neurotoxic effects, the latter of which is believed to involve 
their interaction with proteins other than acetylcholinesterase. However, few OP-binding proteins have been identified that 
may have a direct role in OP-induced delayed neurotoxicity. Given their ability to disrupt  Ca2+ homeostasis, a key aim of the 
current work was to investigate the effects of sub-lethal neurite outgrowth inhibitory levels of OPs on the  Ca2+-dependent 
enzyme tissue transglutaminase (TG2). At 1–10 µM, the OPs phenyl saligenin phosphate (PSP) and chlorpyrifos oxon 
(CPO) had no effect cell viability but induced concentration-dependent decreases in neurite outgrowth in differentiating 
N2a neuroblastoma cells. The activity of TG2 increased in cell lysates of differentiating cells exposed for 24 h to PSP and 
chlorpyrifos oxon CPO (10 µM), as determined by biotin-cadaverine incorporation assays. Exposure to both OPs (3 and/or 
10 µM) also enhanced in situ incorporation of the membrane permeable substrate biotin-X-cadaverine, as indicated by West-
ern blot analysis of treated cell lysates probed with ExtrAvidin peroxidase and fluorescence microscopy of cell monolayers 
incubated with FITC-streptavidin. Both OPs (10 µM) stimulated the activity of human and mouse recombinant TG2 and 
covalent labelling of TG2 with dansylamine-labelled PSP was demonstrated by fluorescence imaging following SDS-PAGE. 
A number of TG2 substrates were tentatively identified by mass spectrometry, including cytoskeletal proteins, chaperones 
and proteins involved protein synthesis and gene regulation. We propose that the elevated TG2 activity observed is due to 
the formation of a novel covalent adduct between TG2 and OPs.
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Introduction
It is well established that many commercially available 
organophosphorous compounds (OPs) used as oil addi-
tives (e.g., tricresyl phosphate; TCP) and insecticides (e.g., 
chlorpyrifos; CPF), inhibit the activities of serine hydro-
lases such as acetyl and butyryl cholinesterase (Aldridge 
1954; Chambers and Levi 1992; Gupta 2006; Kamanyire 
and Karralliede 2004). However, they are also capable of 
inducing delayed neurodegenerative and/or developmental 
effects through covalent interactions with non-cholinest-
erase protein targets (Ray and Richards 2001; Hargreaves 
2012; Sánchez-Santed et al. 2016).
For example, TCP induces a neurodegenerative condi-
tion known as OP-induced delayed neuropathy (OPIDN), 
which was associated with a major outbreak of Ginger 
Jake poisoning during the years of prohibition in the USA 
(Bishop and Stewart 1930; Zeligs 1938). The clinical 
signs of OPIDN do not appear until up to several weeks 
following exposure and are characterised by wrist drop 
and a flaccid paralysis (Abou-Donia and Lapadula 1990; 
Hargreaves 2012). The onset of OPIDN is preceded by a 
number of early molecular lesions, such as irreversible 
inhibition of neuropathy target esterase (NTE), disrupted 
 Ca2+ homeostasis, proteolytic degradation and altered 
phosphorylation of cytoskeletal proteins (Hargreaves 
2012) in the central and peripheral nervous systems. It 
is known that TOCP (i.e., the ortho isomer of TCP) is 
the main inducer of OPIDN by TCP formulations (Abou-
Donia and Lapadula 1990; Harris et al. 1997) following 
its metabolic conversion into saligenin cyclic-o-tolyl phos-
phate (SCOTP), which is a more potent inhibitor of NTE 
but, unlike OPs used as pesticides, a weak inhibitor of 
AChE (Lotti and Johnson 1978). A number of cell culture 
studies have shown that phenyl saligenin phosphate (PSP), 
a structural analogue of SCOTP, inhibits the outgrowth of 
neurites in differentiating neuroblastoma cells in associa-
tion with complete inhibition of NTE, increased activation 
of ERK 1/2, and transient hyperphosphorylation followed 
by a reduction in the protein levels of neurofilament heavy 
chain (Hargreaves et al. 2006).
On the other hand, the main acute toxicity target of 
CPF, after its conversion to chlorpyrifos oxon (CPO) by 
cytochrome P450-mediated desulphuration, is AChE, the 
inhibition of which leads to the accumulation of acetylcho-
line and, potentially, subsequent cholinergic stress (Saun-
ders et al. 2012; Hargreaves 2012). However, CPF also 
exhibits delayed neurotoxic effects in developing rodent 
brains, following exposure at doses causing non-acute 
inhibition of AChE activity but able to inhibit protein and 
DNA synthesis, thus affecting the normal development of 
the brain (Grandjean and Landrigan 2014; Lee et al. 2015).
It has been shown that CPF and its metabolites induce 
neurodevelopmental toxicity in embryonic stem cell models 
of neural differentiation, as indicated by characteristic pat-
terns of disruption of differentiation marker gene expression, 
via a mechanism that is dependent on the expression of NTE 
but not on the inhibition of its esterase activity (Estevan et al. 
2014; Sogorb et al. 2016). In vitro studies have also shown 
that CPF and CPO inhibit neurite outgrowth (Howard et al. 
2005; Sachana et al. 2001, 2008; Yang et al. 2008; Flaskos 
et al. 2011), proliferation and DNA synthesis in neuronal and 
glial cell lines (Garcia et al. 2001; Qiao et al. 2001). CPF 
interferes with the AChE transduction cascade (Yang et al. 
2008), and with transcriptional events by affecting AP-1 
and SP1 nuclear transcription factors that are involved in 
neuronal cell differentiation (Garcia et al. 2001; Crumpton 
et al. 2000), and with neurotransmission (Slotkin and Sei-
dler 2007). CPF also affects the adenylate cyclase signalling 
pathway (Garcia et al. 2001) that controls the formation of 
cAMP, which acts as an important switch signal to activate 
cell differentiation (Cooper and Hausman 2004).
Glial cells exposed to CPF exhibit an increase in ROS for-
mation (Saulsbury et al. 2009). The creation of ROS is not 
associated with direct chemical actions; rather, it involves 
the effects of CPF on cell metabolism (Crumpton et al. 
2000). Studies on cultured cells have indicated that elevated 
levels of ROS can disrupt  Ca2+ homeostasis (Xu et al. 2011), 
which could consequently interfere with the regulation of 
 Ca2+ dependent proteins.
Of interest to the present study are the transglutaminases 
(TGs), which comprise a family of  Ca2+ dependent enzymes 
that catalyse the post-translational modification of proteins 
(Lorand and Graham 2003; Bergamini et al. 2011). Tissue 
TG-associated enzymatic functions, such as the covalent 
cross-linking of proteins and amine incorporation into pro-
teins, are associated with tissue stabilization and with the 
prevention of and protection from bodily injury. However, 
TG2 activity is inappropriately activated in some neuro-
pathologies (Kim et al. 2002), thus making it a potential 
therapeutic target.
Tissue transglutaminase (TG2) plays an important role 
in several processes that occur in normal neural tissues. For 
example, it is involved in the plasticity and stabilization of 
the synapse in the CNS by formation of protease-resistant 
protein crosslinks (Festoff et al. 2001). It is also involved 
in the suppression of catecholamine release from neurons, 
generating a negative feedback that will also prevent an 
excessive release of transmitters. Tissue TG expression and 
transamidase activity are required for neurite outgrowth in 
differentiating neuroblastoma cells (Tucholski et al. 2001) 
and rat cerebellar granule neurons (Mahoney et al. 2000). 
It was suggested that this effect involved TG2-mediated 
increases in cAMP production due to enhanced activa-
tion of cAMP response element binding protein (CREB) 
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(Tucholski and Johnson 2003), a transcription factor that 
modulates synaptic plasticity, cell survival and cell differ-
entiation (Duman et al. 2000). The presence of TG2 and its 
cross-linking activity have also been detected in the growth 
cones of neurites produced by cultured cerebellar granule 
neurons, in which several substrates for TG2 have been iden-
tified (Sugitani et al. 2006).
As TG2 is a  Ca2+ dependent enzyme, its activity could be 
disrupted by altered  Ca2+ homeostasis, as well as by elevated 
levels of ROS, phenomena which are known to be induced 
by OPs (Giordano et al. 2007; Ientile et al. 2007). Prelimi-
nary studies by our group have shown that exposure to PSP 
results in disruption of TG2 activity monitored in lysates 
from mitotic N2a and HepG2 cells after 24 h exposure. It 
is also interesting to note that TG2 protein levels suffered a 
decrease in PSP-treated N2a cells but increased in HepG2 
cells, suggesting that the changes in the protein levels could 
have been responsible for the differences in the observed 
effects (Harris et al. 2009a).
Given the emerging role of TG2 in neurite outgrowth 
and neural differentiation, either through its expression or 
its catalytic activities, coupled with its potential involve-
ment in neurotoxicity, the aim of this study was to explore 
the modulation of TG2 activity by exposure to the OPs PSP 
and CPO in differentiating mouse N2a neuroblastoma cells.
Materials and methods
Unless otherwise specified, all reagents were purchased 
from Sigma Aldrich Company  Ltd. (Poole, UK). Dulbecco’s 
modified Eagle’s medium (DMEM) with 4.5 g/L glucose 
and 2 mM L-glutamine was obtained from Lonza (Viviers, 
Belgium). Cell culture plastic ware and other cell culture 
reagents were purchased from Scientific Laboratory Supplies 
(SLS, Wilford, UK). The N2a and C6 cell lines were from 
obtained from ATCC and ECACC, respectively.
Maintenance and differentiation of N2a cells
Cells were grown as monolayers in T75 flasks with 20 ml 
growth medium (high glucose DMEM supplemented with 
10% v/v foetal bovine serum (FBS), 2 mM L-glutamine, 
penicillin (100 units/ml) and streptomycin (100 μg/ml)), 
using a humidified incubator at 37 °C and an atmosphere 
of 5%  CO2/95% air. Cells were sub-cultured on reaching 
approximately 80–90% confluence. For differentiation 
experiments, cells were seeded at 50,000 cells/ml into 
24-well plates (25,000 cells/well), T25 (500,000 cells) or 
T75 flasks (2 million cells) in growth medium and allowed 
24 h recovery before the induction of cell differentiation in 
the absence and presence of OPs. For this, stock solutions 
of OPs were dissolved in dimethyl sulphoxide (DMSO) 
and diluted in pre-warmed serum-free medium contain-
ing 0.3 mM dibutyryl cAMP, immediately before use, to 
final concentrations of 1–10 µM. The final concentration 
of DMSO was 0.5% (v/v), which was also added to control 
cells. In some experiments, as described below, to confirm 
the involvement of TG2, cells were pre-incubated for 1 h 
with the irreversible TG2 specific inhibitor Z-DON-Val-
Pro-Leu-OMe (ZDON; Zedira, GmbH, Germany), prior 
to the induction of cell differentiation. This was added 
at a final concentration of 100 μM (Almami et al. 2014).
Measurement of cell viability and neurite outgrowth
To determine the effects of OPs on cell viability, cells 
were seeded in T25 flasks (500,000 cells in 10 ml growth 
medium) and cultured for 24  h prior to the induction 
of differentiation in the absence and presence of OPs 
(1–10 µM), as described above. Following exposure, the 
cells were detached and viable cell counts determined 
by Trypan Blue exclusion using a TC-20 automated cell 
counter (BioRad, Hemel Hempstead, UK) after a 1:1 dilu-
tion with Trypan Blue solution (0.4% v/v; BioRad, Hemel 
Hempstead, UK).
Neurite outgrowth was monitored by high content analy-
sis (HCA) of monolayers immunofluorescently stained with 
monoclonal antibody 2G10, which recognises βIII-tubulin, 
using an  ImageXpressMICRO imaging system (Molecular 
Devices, Oxford, UK), as described previously (Sindi et al. 
2016). Significant outgrowth was recorded for any cell with 
at least one stained neurite longer than 5 µm in length.
Preparation of cell lysates
After the appropriate treatments, cell monolayers were 
rinsed twice with 2 ml of chilled PBS, lysed with 500 μl 
of ice-cold lysis buffer consisting of 50 mM Tris buffer pH 
8.0, 0.5% (w/v) sodium deoxycholate, 0.1% (v/v) protease 
inhibitor cocktail III (Millipore, Watford, UK) and 1% (v/v) 
HALT™ Phosphatase Inhibitor Cocktail (1:100; Thermo 
Fisher Scientific, Paisley, UK). Cell lysates were scraped and 
clarified by centrifugation at 4 °C for 20 min at 14 000 × g. 
Supernatants were collected and stored at − 20 °C. Pro-
tein concentration was measured by the bicinchoninic acid 
(BCA) protein assay, based on the method of Stoscheck 
(1990) using a kit from Sigma Aldrich (Poole, UK). For 
Western blot analysis, cell monolayers were rinsed as above, 
then lysed with 500 μl of 0.1% (w/v) sodium dodecyl sul-
phate (SDS) in PBS (pre-heated to 100 °C), after which the 
suspension was heated at 100 °C for 5 min and then cen-
trifuged at 100,000 g for 30 min, before supernatants were 
collected and stored at − 20 °C.
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Measurement of TG2‑mediated amine incorporation 
in cell lysates
Biotin-cadaverine assays were performed on cell lysates by 
the method of Slaughter et al. (1992) as modified by Lil-
ley et al. (1998). For this, 96-well microtitre plates (Nunc 
Maxisorp; SLS, Wilford, UK) were coated overnight at 
4 °C with N’,N’dimethylcasein (10 mg/ml in 100 mM Tris 
buffer pH 8.0; 250 µl/well). The plate was washed twice 
with distilled water and blocked with 250 μl of 3% (w/v) 
BSA in 0.1 M Tris buffer, pH 8.0 and incubated for 30 min 
at 37 °C. The plate was washed twice before adding 150 μl 
of 100 mM Tris buffer, pH 8.0, containing 225 μM biotin-
cadaverine (Fisher Scientific, Loughborough, UK), with 
2 mM β-mercaptoethanol and either 6.67 mM calcium chlo-
ride to activate or 13.3 mM EDTA to inactivate TG2. The 
reaction was started by the addition of 50 μl of samples or 
positive control (50 ng Guinea pig liver TG2) and negative 
control (Tris buffer). After incubation for 1 h at 37 °C, plates 
were washed as before, after which 200 μl of 100 mM Tris 
buffer pH 8.0, containing horseradish peroxidase (HRP)-
conjugated ExtrAvidin™ (1:500 dilution) were added to 
each well and the plate incubated at 37 °C for 45 min then 
washed as before. The plates were developed by incubation 
at room temperature for 15 min with 200 μl of freshly made 
developing buffer (7.5 μg/ml 3, 3′, 5, 5′ tetramethylbenzi-
dine and 0.0005% (v/v)  H2O2 in 100 mM sodium acetate pH 
6.0. The reaction was terminated by adding 50 μl of 5.0 M 
sulphuric acid and the absorbance read at 450 nm. One unit 
of TG2 was defined as a change in absorbance at 450 nm of 
1.0 per hour. Each experiment was performed in triplicate.
Measurement of TG2‑mediated amine incorporation 
in situ
N2a cells were seeded into ibidi µ-slide cell culture treated 
8-well chamber slides (Thistle Scientific, Glasgow, UK), at 
50,000 cells/ml, adding 300 μl of medium per well, and cul-
tured for 24 h in growth medium. Cells were then treated for 
1 h with or without the TG2 inhibitors Z-DON (100 µM) and 
induced to differentiate as described above by the addition 
of differentiation medium containing either 3 or 10 µM PSP 
or 10 µM CPO for 24 h. During the last 4 h of differentia-
tion, 1 mM biotin-X-cadaverine (5-(((N-(biotinoyl)amino)
hexanoyl)amino) pentylamine), trifluoroacetic acid salt; 
Fisher Scientific, Loughborough, UK) was added. Follow-
ing treatment, cells were fixed with 3.7% (w/v) paraform-
aldehyde in PBS for 15 min at room temperature, before 
being permeabilised with 0.1% (v/v) Triton-X100 in PBS 
for 15 min at room temperature. Each of the above steps was 
followed by three 5 min washes with PBS. Cell monolayers 
were blocked by incubation with 3% (w/v) BSA in PBS for 
1 h at room temperature, after which biotin-X-cadaverine 
incorporation was detected by incubation with fluorescein 
isothiocyanate (FITC)-conjugated ExtrAvidin® (green fluo-
rescence) diluted 1:200 in blocking buffer, for 1 h followed 
by 3 PBS washes, as described above. Nuclei were stained 
with blue fluorescence (DAPI; Invitrogen, UK) and images 
viewed in an epifluorescence microscope.
In situ labelling for gel based detection of proteins 
serving as substrates for TG2
For this, N2a cell monolayers were induced to differentiate 
in T75 flasks (2 million cells per flask) in the presence and 
absence of OPs, adding 1 mM biotin-X-cadaverine (Fisher 
Scientific, Loughborough, UK) for the last 4 h of differentia-
tion. Cell monolayers were lysed as described by Singh et al. 
(1995), after which proteins in cell lysates were subjected 
to SDS-PAGE (40 μg/well) and transferred to nitrocellu-
lose membranes (Laemmli, 1970; Towbin et al. 1979). The 
biotin-cadaverine labelled proteins were detected by probing 
blots with  ExtrAvidin®-HRP and visualized by enhanced 
chemiluminescence (ECL). In some experiments, biotin-
cadaverine labelled proteins were enriched using CaptAvi-
din™ agarose (Life Technologies Ltd., Paisley, UK) prior to 
SDS-PAGE, as described by Almami et al. (2014).
Proteomic analysis of biotin‑cadaverine labelled 
proteins
Following labelling with 1 mM biotin-X-cadaverine, biotin-
cadaverine labelled proteins were extracted, as described 
above. The proteins labelled with biotin- cadaverine were 
purified using CaptAvidin™ agarose (Life Technologies 
Ltd., Paisley, UK) prior to polyacrylamide gel electropho-
resis in the presence of SDS (SDS-PAGE) (Almami 2014). 
Protein bands were visualized using InstantBlue protein 
stain. CaptAvidin-captured proteins with molecular weights 
matching bands showing increased labelling on gels of 
lysates from cells differentiated in the presence of PSP that 
was attenuated by pre-treatment with ZDON, were excised 
and subjected to in gel digestion, as described by Aldubayan 
et al. (2017). Briefly, gel bands were excised from the gel 
and cut into small pieces using a sterile scalpel. The gel 
pieces were de-stained with freshly prepared 100% metha-
nol and 50 mM  (NH4)HCO3 (1:1 v/v). Protein bands were 
subjected to reduction and alkylation, by sequential incu-
bation with 25 mM DTT in 50 mM  (NH4)HCO3 followed 
by 55 mM iodoacetamide in 50 mM  (NH4)HCO3 solution. 
The gel pieces were then processed for trypsin digestion 
(Trypsin Gold; Promega, Southampton, UK) over night at 
37 °C. The reaction was terminated by adding 0.5% (v/v) 
trifluroacetic acid (TFA) to a final concentration of 0.5% 
(v/v) and digested proteins were recovered in the supernatant 
following centrifugation.
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Mass spectrometry and protein identification
The full profiling of enriched biotin-cadaverine proteins 
was achieved by LC–MS/MS. Briefly, samples were 
injected by trap-elute (4 µL) using an Eksigent 425 LC 
system (trap: YMC triart  C18 0.3 × 5 mm, 300 µm ID. Ana-
lytical column: YMC Triart  C18 150 × 0.3 mm, 3 µm, 5 µL/
min) into a SCIEX TripleTOF 6600 mass spectrometer in 
Information Dependent Acquisition (IDA, top 30) mode 
via gradient elution (mobile phase A: 0.1% formic acid; 
B: acetonitrile in 0.1% formic acid) over 87 min (2% to 
30% B over 68 min; 40% B at 72 min followed by col-
umn wash and re-equilibration) (Aldiss et al. (2019). Mass 
spectrometry raw data were processed using ProteinPilot 
5.02 (SCIEX, Warrington, UK) against the SwissProt 
mouse database (January 2019) and 1% FDR protein cut-
off applied.
Statistical analysis
Quantitative data are expressed as mean ± SEM for a mini-
mum of 3 independent experiments. Statistical significance 
of differences was determined by one-way or two-way 
ANOVA (as appropriate), followed by Tukey’s post hoc test, 
using GraphPad  Prism® software. A significant difference 
was assumed if P < 0.05.
Results
Effects of PSP on N2a cell viability and neurite 
outgrowth
The ability of PSP to affect the viability and differentia-
tion of N2a cells was monitored by Trypan Blue exclusion 
and HCA, respectively. Over the concentration range tested 
Fig. 1  Effects of PSP and CPO on the viability and differentiation 
of N2a cells. N2a cells were induced to differentiate for 24 h in the 
absence and presence of PSP (a, b) and CPO (c, d) at 1–10 µM. They 
were then either detached and incubated with Trypan Blue solu-
tion to determine cell viability (a, c) or fixed and stained by indirect 
immunofluorescence with anti-βIII tubulin antibody for determination 
of neurite outgrowth by HCA (c, d), as described in “Materials and 
methods”. Data are expressed as mean ± SEM for at least 3 independ-
ent experiments. Asterisks indicate the level of statistical significance 
of differences (***P < 0.001, **P < 0.01, *P < 0.05)
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(1–10 µM) PSP had no statistically significant effect on the 
exclusion of Trypan Blue (Fig. 1a). It did, however, induce 
a concentration-dependent reduction in average neurite 
length, as indicated by HCA of differentiating cell monolay-
ers stained by indirect immunofluorescence using anti-βIII 
tubulin antibody (Fig. 1b). Similar trends were observed in 
the case of treatment with CPO (Fig. 1c, d).
Effect of PSP on TG2 activity in differentiating N2a 
cells
For initial studies of the ability of PSP to disrupt TG2 
activity, lysates prepared from N2a cells induced to differ-
entiate in the presence and absence of 10 μM PSP or CPO 
in serum-free medium containing dibutyryl cAMP, were 
subjected to assays for the incorporation of biotin cadav-
erine, which acts as the acyl-acceptor for TG2. The data 
shown in Fig. 2 show a slight increase in TG2 activity on 
cell differentiation and a statistically significant increase in 
activity on differentiation in the presence of PSP compared 
to control undifferentiated cells. In the case of PSP-treated 
cells that were co-treated with the TG2 inhibitor ZDON 
there was a significant decrease in amine incorporation 
compared to cells treated with PSP alone. Similar results 
were obtained for CPO exposure.
It was then of interest to determine whether the same 
trend would be observed for TG2 activity in  situ. As 
shown in Fig. 3, there was an apparent increase in the 
level of biotin-X-cadaverine incorporation into selected 
protein bands on Western blots of lysates prepared from 
N2a cells induced to differentiate in the absence and pres-
ence of PSP (3, 10 µM) compared to non-OP-treated con-
trol cells, with molecular weights ranging from ~ 25 to 
150 kDa, as indicated by horizontal arrows (Fig. 3). The 
corresponding bands had labelling similar to that of con-
trols when cells were co-treated with the TG2 inhibitor 
ZDON (100 µM). Similar results were observed for lysates 
prepared from differentiating N2a cells exposed to 10 µM 
CPO (Fig. 3). As shown in Fig. 4, densitometric quanti-
fication of whole lanes showed a statistically significant 
Fig. 2  Effects of PSP and CPO on TG2 activity in cell lysates from 
differentiating N2a cells. Mitotic N2a cells were pre-treated in the 
absence or presence of the TG2 inhibitor Z-DON (100 μM) for 1 h 
and then subjected to differentiation for 24 h in serum-free medium 
containing 0.3  mM dibutyryl cAMP, in the absence or presence of 
PSP or CPO (both at 10 µM). Cell lysates were subjected to biotin-
cadaverine incorporation assays, as described in “Materials and meth-
ods”. Data points represent the mean ± SEM of TG2 specific activity 
from 3 independent experiments. Data analysis was performed using 
one-way ANOVA with the Tukey post hoc test. Asterisks indicate 
the level of statistical significance of differences from the control 
(***P < 0.001, **P < 0.01, *P < 0.05)
Fig. 3  Western blot analysis of the effects of PSP on in situ TG activ-
ity in differentiating N2a cells. Cells were pre-incubated for 1 h with 
(f, h) or without (a–e and g) the TG2 inhibitor Z-DON (100  μM) 
before the induction of cell differentiation for 24  h in the absence 
and presence of 3 μM (a, b) or 10 μM PSP and CPO (c–h). Well (c) 
contained non-differentiated (i.e., mitotic) cell lysate protein. For the 
last 4  h of treatments, 1  mM biotin-X-cadaverine was added. The 
total protein extract was resolved by SDS-PAGE (40 μg per lane) and 
transferred onto nitrocellulose membranes. Biotin-cadaverine labelled 
proteins were detected using  ExtrAvidin®-HRP. Samples were subse-
quently analysed on a separate blot using an anti-GAPDH antibody 
as a control for protein loading (lower panel). The arrows point to 
biotin-ExtrAvidin-labelled proteins that show increased labelling fol-
lowing exposure to PSP or CPO that was attenuated by pre-treatment 
with ZDON
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increase in overall band intensity on the developed blots 
from lysates of OP-treated cells compared to the non-OP-
treated controls. These biotin-cadaverine labelled proteins 
showed reduced staining on western blots of lysates from 
cells that were incubated in the presence of both OP and 
the TG2 inhibitor ZDON, the activity returning to basal 
levels. In situ labelling was also monitored by fluorescence 
microscopy using FITC-labelled ExtrAvidin™, for which 
a qualitatively similar pattern of staining was observed, 
as shown in Fig. 5.
Direct effects of organophosphates on human 
and mouse recombinant TG 2 activity
To study the possibility of a direct effect of PSP on TG2 
activity, human and mouse recombinant TG2 were assayed 
in the absence and presence of 10 µM PSP or CPO using 
the biotin-cadaverine incorporation assay (Fig. 6). The 
data obtained indicated a significant OP-induced increase 
in recombinant TG2 activity. All activity was blocked 
by co-treatment with 100  μM ZDON. To determine 
whether this reflected covalent adduct formation between 
TG2 and PSP, recombinant TG2 was incubated with a 
dansylamine-labelled analogue of PSP, which had previ-
ously been used to identify PSP adducts in cardiomyocyte-
like cells (Felamban et al. 2015). The gel images in Fig. 7 
show that both human and mouse recombinant TG2 incu-
bated with dansylamine-labelled PSP were detectable as 
fluorescent bands after separation by SDS-PAGE.
Effects of PSP on the intracellular distribution TG2 
and α‑tubulin
It was of further interest to determine whether exposure to 
OPs affected the intracellular distribution of TG2. As shown 
in Fig. 8a, b, immunofluorescence staining with a mono-
clonal antibody that recognises α-tubulin revealed a similar 
staining pattern with respect to relative intensity of neurite/
cell body staining in control and PSP-treated cells. By con-
trast the relative intensity of staining of neurite: cell body 
staining with two different anti-TG2 antibodies was higher 
in PSP-treated cells than in the controls (Fig. 8c–f).
Identification of protein substrates of TG2‑mediated 
transamidase activity
Prior to identification of TG2 substrates, biotin-cadaver-
ine labelled proteins were enriched using CaptAvidin™ 
agarose (Almami et al. 2014). Biotin-cadaverine labelled 
TG2 substrate proteins captured by CaptAvidin™ beads 
were separated by SDS-PAGE and proteins revealed 
by staining with Coomassie Brilliant Blue. The protein 
bands corresponding in molecular weight to those show-
ing activation and inhibition of TG2-mediated biotin-
cadaverine incorporation activity were excised from gels 
(arrows in Fig. 3). The proteins were then extracted from 
gel pieces and subjected to trypsin digestion after reduc-
tion and alkylation, as described in “Materials and meth-
ods”. Digested samples were then analysed by LC–MS/
MS, as a result of which multiple proteins were identi-
fied within each Coomassie-stained band. Proteins with 
at least 3 peptide matches following ProteinPilot search-
ing against the SwissProt mouse database are listed in 
Table 1. Proteins that were identified as potential TG2 
substrates ranged in molecular weight from approxi-
mately 30 to 150 kDa. These included cytoskeletal pro-
teins (e.g., vimentin, peripherin, lamin B1, tubulin and 
actin), chaperone and folding proteins (e.g., HSPs 60, 70 
and 90),  Ca2+ and phospholipid binding proteins (e.g., 
matrin 3), mitochondrial proteins (e.g., MICOS complex 
subunit mic60, Cytochrome b-c1 complex subunit 2 and 
ATP-citrate synthase), in addition to several other pro-
teins involved in the regulation of protein synthesis (e.g., 
elongation factors 1-alpha 1, 1-alpha 2 1-gamma and vari-
ous ribosomal proteins), gene expression (e.g., various 
isoforms of histone H1), and metabolism (e.g., GAPDH).
Fig. 4  Densitometric analysis of biotin-cadaverine incorporation into 
proteins detected on Western blots of cell lysates from differentiating 
N2a cells. Following in situ labelling of differentiating N2a cells with 
biotin-X-cadaverine, Western blots of cell lysates (shown in Fig.  3) 
were probed with  ExtrAvidin®-HRP, as described in “Materials and 
methods”. Densitometric analysis of each lane (total labelled protein) 
was carried out using GelQuant software and the data are expressed 
as the percentage of basal TG2 substrate protein levels ± SEM after 
GAPDH normalization. Data analysis was performed using one-way 
ANOVA with the Tukey post hoc test. Asterisks indicate the level of 
statistical significance of differences from the differentiating cell con-
trol ***P < 0.001, **P < 0.01, *P < 0.05
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Fig. 5  Measurement of the effects of organophosphates on in  situ 
TG2 activity in differentiating N2a cells using  Extravidin®-FITC. 
Cells were seeded in chamber slides and incubated with biotin-X-
cadaverine after treatment with or without 10 µM PSP, 10 µM CPO 
and ZDON, followed by  Extravidin®-FITC (green), as described 
in “Materials and methods”. Shown are typical images from a rep-
resentative experiment (one of three). Images show typical fields of 
N2a cells, treated for 1 h with or without the TG2 inhibitor Z-DON 
(100 μM) before the induction of differentaition in the presence and 
absence of 10  μM PSP or CPO for 24  h. For the last 4  h of treat-
ments, 1  mM biotin-X-cadaverine was added, except for one set of 
untreated cells used as a negative control with no biotin-cadaverine. 
Nuclei were stained with DAPI (blue). The original magnification of 
the images was 20×. Bar represents 200 µm
of bands of interest in CaptAvidin-captured proteins sepa-
rated by SDS-PAGE allowed the identification of a number 
of known and novel potential substrates, none of which had 
been previously identified as substrates in N2a cells. These 
could be grouped into several categories based on function, 
including cytoskeletal proteins, chaperones and proteins 
involved in gene expression and/or protein synthesis.
For example, 78 kDa glucose-regulated protein Hspa5 
chaperone is a quality control protein the endoplasmic retic-
ulum lumen, involved in the correct folding of proteins and 
degradation of misfolded proteins (Weng et al 2011). It also 
plays a key role in neurological disorders, acting as a stress 
sensor, and in embryonic development of the central nerv-
ous system (Zhang et al. 2007). It also has an essential role 
in protection from neuronal apoptosis (Wang et al. 2010). 
Indeed, a proteomic analysis study conducted by our group 
before has demonstrated upregulation of 78 kDa glucose-
regulated protein in N2a neuroblastoma cells following 
exposure to the organophosphorous compound diazinon 
(Harris et al. 2009b). This protein has been already identi-
fied as a TG2 substrate in H9c2 cardiomyocyte-like cells 
(Almami 2014). Whether its modification by TG2- mediated 
transamidation enhances or attenuates its activity remains to 
be determined.
Interestingly, an IgE-binding protein was identified in 
CaptAvidin-captured proteins as a novel protein substrate 
for TG2. This may reflect the fact IgE receptors have been 
detected on the surface of neuronal cells and are thought 
to be involved in a variety of inflammatory responses of 
sensory neurones to IgE-antigen complexes (Andoh and 
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Kuraishi 2004; Van der Klejj et al. 2010; Liu et al. 2017). 
This finding is consistent with the possibility that TG2-
mediated amine incorporation may be involved in the modu-
lation of such processes.
Several of the other substrates identified in CaptAvidin-
captured protein extracts are involved in the regulation of 
protein synthesis and gene expression, including a number 
of histones, elongation factors and RNA-binding proteins, 
etc. Similar types of proteins have been identified as TG2 
substrates in studies of adenosine receptor stimulation in 
cardiomyocyte-like cells (Almami et al. 2014; Vyas et al. 
2016, 2017). The nuclear matrix protein matrin 3, on the 
other hand, is a potentially novel TG2 substrate; it is modu-
lated by  Ca2+/calmodulin binding, cleaved by caspases and 
is involved in the control of mRNA stability (Valencia et al. 
2007; Salton et al. 2011). Mutations in the matrin 3 gene are 
linked with familial forms of amyotrophic lateral sclerosis, 
suggesting an important role in neuroprotection (Johnson 
et al. 2014). It may be that TG2-mediated amine incorpora-
tion can modulate the activity of these groups of proteins 
during OP-exposure and that this is partly responsible for 
changes observed in gene expression and protein levels in 
previous studies on developmental neurotoxicity in brain and 
cultured cell models (Garcia et al. 2001; Qiao et al. 2001; 
Howard et al. 2005; Sachana et al. 2001, 2008; Yang et al. 
2008; Flaskos et al. 2011; Grandjean and Landrigan 2014; 
Lee et al. 2015).
Actin and tubulin are the core components of microfila-
ments and microtubules, respectively, and are significantly 
expressed in nerve tissue and differentiated neuroblastoma 
cell lines (Oh et al. 2006). Two isoforms of both actin and 
tubulin have been identified as TG2 substrates by us previ-
ously, following stimulation of adenosine receptors in H9c2 
cells (Vyas et al. 2016, 2017) and are well established TG2 
substrates. A covalent interaction of CPO with tubulin beta-5 
was also observed in extracts from mouse brain (Jiang et al. 
2010) suggesting that it is an important target in OP-induced 
delayed neurotoxicity. The beta-5 tubulin isoform was previ-
ously identified as a substrate for TG2 in cardiomyocyte-like 
cells (Vyas et al. 2016, 2017), although other isoforms of 
both alpha and beta tubulin are also recognised substrates 
on the online database (https ://genom ics.dote.hu/wiki/index 
.php/). The identification of vimentin and peripherin as sub-
strates suggests that proteins in all 3 cytoskeleton networks 
(i.e., microtubules, microfilaments and intermediate fila-
ments) are targeted by TG2 in OP-treated cells.
Upregulation of Stip1 is correlated with neuroprotection 
during ischemic insult; this protein is released from astro-
cytes and it causes increases in intracellular  Ca2+ levels by 
activation of the alpha-7-nicotinic ACh receptor (Beraldo 
et al. 2013). Stip1, along with HSP 90-beta, stress-70 cog-
nate 71 kDa and HSP 60 are chaperone proteins involved in 
cytoprotection, modulation of protein folding and transport, 
and have been shown to be up-regulated after a toxic insult 
by the OP nerve agent sarin in mouse brain (Chaubey et al. 
2017). The level of Stip1 also increased in the brain follow-
ing ischaemia, inducing neuroprotective signals that rescue 
Fig. 6  Direct effects of organophosphates on recombinant TG 2 activ-
ity. TG2-mediated transamidase activity of human and mouse recom-
binant TG2 was determined using the biotin-cadaverine incorporation 
assay as described in “Materials and methods”. Data points represent 
the mean specific activity ± SEM. Data analysis was performed using 
two-way ANOVA followed by the Dunnett’s post hoc comparison 
test, as indicated. Asterisks indicate the statistical significance of dif-
ferences (***P < 0.001, **P < 0.01, *P < 0.05)
Fig. 7  Formation of covalent adducts between TG2 and PSP. Cova-
lent labelling of human or mouse recombinant TG2 with dan-
sylamine-labelled PSP (D-PSP) was detected in a fluorescence imager 
after SDS-PAGE (upper panels) and Instant Blue staining (CB) of 
total protein in the same samples (lower panels), as indicated
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Fig. 8  Effects of PSP on the dis-
tribution of TG2 and α-tubulin 
in differentiating N2a cells. N2a 
cells were induced to differenti-
ate in chamber slides for 24 h 
in the presence and absence of 
3 μM PSP. Cells were then fixed 
and permeabilised as detailed 
in “Materials and methods”. 
Fixed monolayers were probed 
with monoclonal anti-α-tubulin 
(clone B512) (a, b), and two 
monoclonal antibodies to 
TG2: clones ID10 (c, d) and 
CUB7402 (e, f). Scale bar rep-
resents 20 μm. Arrows indicate 
typical neurites
According to the TRANSDAB database (https ://genom 
ics.dote.hu/wiki/index .php/), some of the identified pro-
teins were already reported as TG2 substrates (Csősz 
et al. 2009), but they have not as yet been identified as 
such in differentiating N2a cells though we have identi-
fied some as TG2 substrates in H9c2 cardiomyocyte-like 
cells. Those previously identified by our group include 
heat shock protein HSP 90-beta, Stress-70 cognate 71 kDa 
and HSP 60 kDa, isoforms of actin and tubulin, myo-
sin-9, elongation factor 1-alpha 1, tropomyosin, vimentin, 
histones and heterogeneous nuclear ribonucleoprotein A1 
(Almami et al. 2014; Vyas et al. 2016, 2017).
Discussion
The results presented in this study show that sub-lethal 
neurite inhibitory concentrations of PSP, an OP associ-
ated with the induction of OPIDN, induced elevated lev-
els of TG2-mediated transamidase activity, as determined 
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Table 1  Identification of TG 2 substrates by mass spectrometry
Band % Coverage Accession number (s) Proteins identified as potential TG2 
substrates
Peptide matches Approx mass (Da)
1 6 Q8VEK3 Heterogeneous nuclear ribonucleopro-
tein U
6 87,918
4 Q8K310 Matrin-3 3 94,630
2.6 Q91V92 ATP-citrate synthase 3 119,728
2 18.4 P58252 Elongation factor 2 14 95,314
3 20.3 P11499 Heat shock protein HSP 90-beta 15 83,281
7 Q8CAQ8 MICOS complex subunit Mic60 5 83,900
4 30.9 P38647 Stress-70 protein, mitochondrial 
(GRP75)
26 73,680
31.7 P63017 Heat shock cognate 71 kDa protein 25 70,871
13.6 Q9D0E1 Heterogeneous nuclear ribonucleopro-
tein M
10 77,649
16.5 P03975 IgE-binding protein 8 62,747
13.3 P14733 Lamin B1 8 66,786
11 P20029 78 kDa glucose-regulated protein 6 72,422
6.7 Q99MN1 Lysine–tRNA ligase 4 67,840
4.5 P26041 Moesin 3 67,767
5 27.2 P63038 60 kDa heat shock protein, mitochon-
drial
16 60,955
15.7 Q60864 Stress-induced-phosphoprotein 1 8 62,582




teins K and L
7-Mar 44,542—63,964
6 25.7 P99024 Tubulin beta-5 chain 13 49,671
22.8 P20152 Vimentin 10 53,688
10.5 Q9D8E6 60S ribosomal protein L4 6 47,154
10.5, 10.4, 10.4, 8.3, 8.7 P68373, P68369, 
P05213, P68368, and 
P05214
Tubulin alpha-1C, 1A, 1B, 4A and 3 
chains
6, 6, 6, 5, 4 49,909/50,136/50,152
/49,924/49,960
11.5, 9.0 P56480, Q03265 ATP synthase subunits β and α, mito-
chondrial
5, 4 56,300/59,753
5.4 P09405 Nucleolin 4 76,723
7.5 P03975 IgE-binding protein 4 62,747
8.6 Q922R8 Protein disulphide-isomerase A6 3 48,100
6.1 P15331 Peripherin 3 54,268
7 38.3 P17182 Alpha-enolase 18 47,141
15.8 P03975 IgE-binding protein 7 62,747
14.2 Q9D8N0 Elongation factor 1-gamma 5 50,061
8.8 P20152 Vimentin 4 53,688
11.5, 11.5 P62631, P10126 Elongation factor 1-alpha 2 and 
1-alpha-1
4, 4 50,454/50,114
8.2, 8.3 Q9ERD7, P99024 Tubulin beta-3 and 5 chains 3, 3 50,419/49,671
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by assays performed on cell lysates prepared following 
treatment and by in situ labelling with the membrane per-
meable substrate biotin-X-cadaverine. The fact that OP- 
induced increases in transamidase activity in differenti-
ated cells were significantly attenuated by ZDON provided 
further conformation that TG2 was involved.
The possibility that this might be due to a direct effect 
of PSP on TG2 was confirmed in assays using mouse and 
human recombinant TG2, which also showed elevated 
levels of biotin-cadaverine incorporation in the presence 
of PSP. This suggested that TG2 could be a novel PSP 
binding protein, which was subsequently confirmed by the 
observation of a fluorescent TG2 band following incuba-
tion with dansylamine-labelled PSP and separation by 
SDS-PAGE, indicating the formation of a novel covalent 
adduct with both mouse and human recombinant TG2.
The fact that similar effects on TG2 activity were 
observed for the oxon metabolite of the organophosphoro-
thioate CPF (i.e., CPO), suggests that other OPs may also 
interact directly with TG2. Given the known importance 
of TG2 in neurite outgrowth (Perry et al. 1995; Mahoney 
et al. 2000; Tucholski et al. 2001, 2003) an important 
morphological determinant of neuronal cell differentia-
tion during development and also in nerve regeneration, 
and the observation of TG2 upregulation in neurodegen-
erative diseases (Kim et al. 2002; Grosso and Mouradian 
2012), our findings suggests that TG2 represents a new 
and highly relevant non-cholinesterase protein target for 
OP-binding. It is possible that OP adduction induces the 
acquisition of a toxic property in TG2, such as that pro-
posed for NTE in OPIDN (Glynn 2000). Alternatively, the 
changes observed may reflect a protective effect of TG2 
upregulation. Indeed, the enrichment of anti-TG2 immuno-
fluorescence staining in surviving neurites in PSP-treated 
cells, compared to those of control N2a cells, is indicative 
of a redistribution of TG2, which is consistent with this 
possibility.
To further investigate the consequences of TG2 upregula-
tion, it was of interest to identify the potential substrates of 
TG2 in OP-induced inhibition of neurite outgrowth. Analysis 
Table 1  (continued)
Band % Coverage Accession number (s) Proteins identified as potential TG2 
substrates
Peptide matches Approx mass (Da)
8 22.8 P20152 Vimentin 10 53,688
17.8 P03975 IgE-binding protein 8 62,747
19.2, 19.2 P63260, P60710 Actin, cytoplasmic 1 and 2 7, 7 41,793/41,737
17.6 Q8VE37 Regulator of chromosome condensa-
tion
6 44,931
11.6 Q91VM5 RNA binding motif protein, X-linked-
like-1
4 42,162
11.5 Q9WV02 RNA-binding motif protein, X chro-
mosome
4 42,301
8.9 Q9D8N0 Elongation factor 1-gamma 4 50,061
11.5 Q9DB77 Cytochrome b-c1 complex subunit 2, 
mitochondrial
5 48,235
8.1 O35685 Nuclear migration protein nudC 3 38,358
9 33.9 P16858 Glyceraldehyde-3-phosphate dehydro-
genase
18 35,810
23.1, 18.4, 30.6 P43277, P15864, P43274 Histones H1.3, H1.2 and H1.4 8, 7, 8 22,100/21,267/21,977
29.3 P14148 60S ribosomal protein L7 8 31,420
28.3 P43276 Histone H1.5 7 22,576
20.8 P97351 40S ribosomal protein S3a 5 29,885
13.5 P70372 ELAV-like protein 1 4 36,169
10.2 P25444 40S ribosomal protein S2 3 31,231
Biotin-cadaverine labelled TG2 substrate proteins captured by captavidin beads were separated by SDS-PAGE and the 9 main bands showing 
increased TG2-mediated labelling were excised and analysed by mass spectrometry. Data shown are for abundant proteins showing a minimum 
of 3 peptide matches determined with 95% confidence levels. Molecular weight (MW) is also indicated in Da, according to values published on 
UniProt. As discussed, some of these are potentially novel TG2 substrates not currently listed on the TRANSDAB database (https ://genom ics.
dote.hu/wiki/index .php/) of Csősz et al. (2009) or identified as potential substrates in our own previous work (Almami et al. 2014; Vyas et al. 
2016, 2017)
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the cell from apoptosis (Beraldo et al. 2015). It would be of 
value to carry out further work to determine the effects of 
increased amine incorporation on the biochemical proper-
ties and functions of this and the other proteins identified 
as potential substrates of TG2 in OP-treated differentiating 
N2a cells.
In conclusion, under conditions that cause inhibition of 
neurite outgrowth, OPs are capable of binding covalently 
to TG2 and activating TG2-mediated transamidase activity, 
targeting a number of proteins essential for the integrity of 
neurites and others involved in the regulation of gene expres-
sion, protein synthesis and protein folding.
It could be that OP adduct formation reduces the  Ca2+ 
requirement for TG2 activation in situ and/or that it binds 
to a regulatory domain that exerts an allosteric effect on 
the active site. Indeed, characterisation of the OP-binding 
sites on TG2 and their role in TG2 modulation will help to 
determine the mechanism involved. Further work will also 
help to determine the precise role of TG2 and its modi-
fied protein substrate in OP-induced inhibition of neurite 
outgrowth.
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